CDx Diagnostics

CDx Diagnostics, the provider of WATS3D, is a pioneer in the detection of Barrett’s esophagus and esophageal dysplasia. The company’s mission of “Empowering Physicians with Innovative Technology to Prevent Esophageal Cancer, One Patient at a Time” is accomplished by WATS3D - a proprietary 3-in-1 diagnostic platform consists of unique tissue sampling, better disease identification via an AI algorithm and proprietary Extended Depth of Focus, and diagnosis by CDx expert GI pathologists. WATS3D has received a recommendation from the ASGE Standards of Practice Guidelines, and several recognitions from medical professional society organizations. It is easy to integrate WATS3D into daily endoscopic workflow. Routine clinical use of CDx testing has already identified thousands of precancers that would otherwise have been missed in time for effective treatment. To learn more, visit www.WATS3D.com.